VR Adviser as of Dec. 31, 2021
Portfolio Holdings for VR Adviser
VR Adviser holds 26 positions in its portfolio as reported in the December 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Instil Bio | 16.1 | $118M | 6.9M | 17.11 | |
| Aclaris Therapeutics (ACRS) | 9.1 | $66M | 4.6M | 14.54 | |
| Travere Therapeutics (TVTX) | 8.5 | $62M | 2.0M | 31.04 | |
| Relmada Therapeutics (RLMD) | 7.0 | $51M | 2.3M | 22.53 | |
| GH Research Ord Sh (GHRS) | 6.4 | $47M | 2.0M | 23.33 | |
| Aadi Bioscience (AADI) | 5.0 | $37M | 1.5M | 24.15 | |
| Miragen Therapeutics (VRDN) | 5.0 | $37M | 1.9M | 19.77 | |
| Marinus Pharmaceuticals (MRNS) | 4.7 | $34M | 2.9M | 11.88 | |
| Celldex Therapeutics (CLDX) | 4.6 | $33M | 865k | 38.64 | |
| Tricida | 4.6 | $33M | 3.5M | 9.56 | |
| LianBio Spons Adr (LIANY) | 4.5 | $33M | 5.4M | 6.16 | |
| Vistagen Therapeutics | 4.3 | $31M | 16M | 1.95 | |
| Chinook Therapeutics | 2.9 | $21M | 1.3M | 16.31 | |
| Graphite Bio | 2.7 | $20M | 1.6M | 12.43 | |
| Nuvalent Inc-a (NUVL) | 2.1 | $15M | 804k | 19.04 | |
| Kinnate Biopharma | 1.9 | $14M | 773k | 17.72 | |
| Athira Pharma (ATHA) | 1.8 | $13M | 1.0M | 13.03 | |
| Centessa Pharmaceuticals Spons Adr (CNTA) | 1.7 | $13M | 1.1M | 11.26 | |
| Atyr Pharma (ATYR) | 1.6 | $12M | 1.6M | 7.47 | |
| Cogent Biosciences (COGT) | 1.3 | $9.3M | 1.1M | 8.58 | |
| Affimed Therapeutics B V | 1.1 | $7.9M | 1.4M | 5.52 | |
| Olema Pharmaceuticals (OLMA) | 1.0 | $7.6M | 817k | 9.36 | |
| CVRX (CVRX) | 0.9 | $6.5M | 533k | 12.23 | |
| Akoya Biosciences (AKYA) | 0.8 | $6.1M | 400k | 15.31 | |
| Astria Therapeutics (ATXS) | 0.4 | $2.9M | 539k | 5.39 | |
| Corvus Pharmaceuticals (CRVS) | 0.1 | $603k | 250k | 2.41 |
